The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was $7.60 for the day, down -0.65% from the previous closing price of $7.65. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 3.61 million shares were traded. IRWD stock price reached its highest trading level at $7.725 during the session, while it also had its lowest trading level at $7.53.
Ratios:
Our analysis of IRWD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.50. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 0.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on January 17, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On December 14, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.
On November 09, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $21.Jefferies initiated its Buy rating on November 09, 2023, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’24 when Duane Jon R bought 6,920 shares for $8.70 per share. The transaction valued at 60,204 led to the insider holds 121,028 shares of the business.
Emany Sravan Kumar bought 10,684 shares of IRWD for $100,216 on Mar 04 ’24. The SVP, Chief Financial Officer now owns 301,733 shares after completing the transaction at $9.38 per share. On Feb 12 ’24, another insider, MCCOURT Thomas A, who serves as the Chief Executive Officer of the company, sold 177,164 shares for $15.24 each. As a result, the insider received 2,699,979 and left with 832,774 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 1189620352 and an Enterprise Value of 1813001728. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.69. Its current Enterprise Value per Revenue stands at 4.095 whereas that against EBITDA is 10.67.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $15.70, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -28.50%, while the 200-Day Moving Average is calculated to be -27.11%.
Shares Statistics:
IRWD traded an average of 4.66M shares per day over the past three months and 2447070 shares per day over the past ten days. A total of 156.35M shares are outstanding, with a floating share count of 151.60M. Insiders hold about 3.15% of the company’s shares, while institutions hold 107.47% stake in the company. Shares short for IRWD as of 1711584000 were 21954392 with a Short Ratio of 4.71, compared to 1709164800 on 15511416. Therefore, it implies a Short% of Shares Outstanding of 21954392 and a Short% of Float of 22.850001.
Earnings Estimates
Current recommendations for the stock of the company come from CrowdStrike Holdings, Inc. analysts. The consensus estimate for the next quarter is $7.60, with high estimates of $40.36 and low estimates of $169.57.
EPS for the following year is $Stocks, with Stocks analysts recommending between $Stocks and $ETF.
